Mediplantex National Pharmaceutical JSC (HNX:MED)
Vietnam
· Delayed Price · Currency is VND 22,800
0.00 (0.00%)
At close: Aug 7, 2025
HNX:MED Ratios and Metrics
Market cap in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Aug '25 Aug 6, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Market Capitalization | 282,948 | 322,660 | 335,070 | 260,610 | 187,775 | 244,924 | Upgrade
|
| Market Cap Growth | -15.83% | -3.70% | 28.57% | 38.79% | -23.33% | - | Upgrade
|
| Enterprise Value | 291,091 | 332,302 | 335,404 | 170,199 | 147,414 | 284,398 | Upgrade
|
| Last Close Price | 22800.00 | 24660.94 | 24749.42 | 18879.37 | 26565.12 | 24861.10 | Upgrade
|
| PE Ratio | 24.24 | 21.16 | 28.53 | 40.94 | 50.11 | 10.03 | Upgrade
|
| PS Ratio | 0.78 | 0.73 | 0.83 | 0.65 | 0.55 | 0.47 | Upgrade
|
| PB Ratio | 0.88 | 0.98 | 1.02 | 0.81 | 1.13 | 1.35 | Upgrade
|
| P/TBV Ratio | 0.88 | 0.98 | 1.02 | 0.81 | 1.13 | 1.35 | Upgrade
|
| P/FCF Ratio | - | 8.57 | - | - | 24.24 | 4.05 | Upgrade
|
| P/OCF Ratio | - | 6.77 | - | 9.94 | 3.02 | 2.74 | Upgrade
|
| EV/Sales Ratio | 0.81 | 0.75 | 0.83 | 0.42 | 0.43 | 0.55 | Upgrade
|
| EV/EBITDA Ratio | 11.68 | 11.04 | 14.83 | 9.12 | 8.00 | 7.64 | Upgrade
|
| EV/EBIT Ratio | 16.90 | 14.97 | 23.65 | 19.71 | 16.58 | 10.45 | Upgrade
|
| EV/FCF Ratio | - | 8.82 | - | - | 19.03 | 4.70 | Upgrade
|
| Debt / Equity Ratio | 0.14 | 0.08 | 0.20 | 0.28 | 0.41 | 0.44 | Upgrade
|
| Debt / EBITDA Ratio | 1.78 | 0.92 | 2.85 | 4.87 | 3.72 | 2.16 | Upgrade
|
| Debt / FCF Ratio | - | 0.74 | - | - | 8.86 | 1.33 | Upgrade
|
| Asset Turnover | 0.65 | 0.84 | 0.64 | 0.67 | 0.68 | 0.96 | Upgrade
|
| Inventory Turnover | 2.91 | 3.68 | 3.12 | 3.38 | 3.05 | 3.60 | Upgrade
|
| Quick Ratio | 0.54 | 0.73 | 0.69 | 0.83 | 0.70 | 0.87 | Upgrade
|
| Current Ratio | 1.41 | 1.46 | 1.32 | 1.22 | 1.04 | 1.21 | Upgrade
|
| Return on Equity (ROE) | 3.55% | 4.63% | 3.62% | 2.61% | 2.16% | 13.93% | Upgrade
|
| Return on Assets (ROA) | 1.94% | 2.62% | 1.41% | 0.91% | 1.09% | 3.12% | Upgrade
|
| Return on Capital (ROIC) | 2.73% | 3.70% | 2.20% | 1.67% | 2.24% | 6.46% | Upgrade
|
| Return on Capital Employed (ROCE) | 5.40% | 6.70% | 4.30% | 2.70% | 5.40% | 15.00% | Upgrade
|
| Earnings Yield | 4.13% | 4.72% | 3.50% | 2.44% | 2.00% | 9.97% | Upgrade
|
| FCF Yield | - | 11.68% | -25.22% | -34.93% | 4.13% | 24.71% | Upgrade
|
| Dividend Yield | 3.95% | - | 3.64% | 2.65% | 0.94% | - | Upgrade
|
| Payout Ratio | - | 72.28% | 54.72% | 138.49% | 354.43% | 38.11% | Upgrade
|
| Buyback Yield / Dilution | 5.83% | - | -32.18% | -49.59% | 0.05% | 0.01% | Upgrade
|
| Total Shareholder Return | 9.78% | - | -28.54% | -46.94% | 0.99% | 0.01% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.